You have access
Screening for novel RyR2 inhibitors by ER Ca2+ monitoring
Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
Molecular Pharmacology September 7, 2023, MOLPHARM-AR-2023-000720; DOI: https://doi.org/10.1124/molpharm.123.000720